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Abstract: Salmonella enterica with the identical antigenic formula 6,7:c:1,5 can be differentiated
biochemically and by disease syndrome. One grouping, Salmonella Paratyphi C, is currently considered
a typhoidal serovar, responsible for enteric fever in humans. The human-restricted typhoidal serovars
(S. Typhi and Paratyphi A, B and C) typically display high levels of genome degradation and are cited as
an example of convergent evolution for host adaptation in humans. However, S. Paratyphi C presents
a different clinical picture to S. Typhi/Paratyphi A, in a patient group with predisposition, raising the
possibility that its natural history is different, and that infection is invasive salmonellosis rather than
enteric fever. Using whole genome sequencing and metabolic pathway analysis, we compared the
genomes of 17 S. Paratyphi C strains to other members of the 6,7:c:1,5 group and to two typhoidal
serovars: S. Typhi and Paratyphi A. The genome degradation observed in S. Paratyphi C was much
lower than S. Typhi/Paratyphi A, but similar to the other 6,7:c:1,5 strains. Genomic and metabolic
comparisons revealed little to no overlap between S. Paratyphi C and the other typhoidal serovars,
arguing against convergent evolution and instead providing evidence of a primary adaptation to pigs
in accordance with the 6,7:c:1.5 strains.
Keywords: host adaptation; convergent evolution; genome degradation; genomic lesions
1. Introduction
Standardisation in the classification and fine typing of Salmonella in the mid-20th century led to
a revolution in our understanding of the biological properties, particularly host associations, of this
heterogenous group of animal pathogens [1,2]. For Salmonella enterica there are six defined subspecies.
Nearly all isolates from humans are from subspecies I, in which more than 1500 serotypes can be
distinguished by their cell wall (O) and flagella (H) antigens [3]. The combination of O:H1:H2
is known as the antigenic formula and each unique combination is given a name. For example
(using the simplified antigenic formulae used by front line diagnostic laboratories) 9:d:- (where “-“
means no antigen) identifies S. Typhi isolates and 2:a:1,5 is S. Paratyphi A. Both of these serovars are
human-restricted and cause enteric fever. The situation, however, is more complex for S. Paratyphi B
where its antigenic formula, 4:b:1,2 is shared by several Salmonella capable of causing mild to severe
disease [4]. The 4:b:1,2 group can be split into subtypes using metabolic ability (e.g., tartrate utilisation),
but these groups do not map to specific host species. For example, the human restricted S. Paratyphi B
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sensu stricto is always tartrate negative, but other 4:b:1,2 tartrate negative strains are highly diverse and
are collectively known as S. Java. To date, only sequence typing has been able to define the phylogroup
of tartrate negative strains that are human restricted [4]. Currently all Salmonella with the antigenic
formula 4:b:1,2 are categorised as dangerous pathogens [5], but this may change as evidence linking
the sub-types to clinical phenotypes accumulates.
The fourth Salmonella serotype considered to be a human restricted enteric fever pathogen is
S. Paratyphi C; this belongs to a highly variable group with the antigenic formula 6,7:c:1,5, for which
subtyping has never been fully resolved [6,7]. The most commonly isolated member of this group,
S. Choleraesuis, has been divided into biotypes (Table 1): sensu stricto and Kunzendorf have a limited
ability to grow using single sugars as a carbon source and differ only in their ability to produce H2S
from sulphates—a test which is difficult to standardise for routine diagnostic use.
Table 1. Differentiation by biochemistry of 6,7:c:1,5 Salmonella.
Dulcitol H2S Mucate
Paratyphi C + + −
Choleraesuis var. sensu stricto − − −
Choleraesuis var. Kunzendorf − + −
Choleraesuis var. Decatur + + +
Typhisuis * − − −
Adapted from the Kauffman White scheme [3]. * Typhisuis is d-tartrate negative in contrast to the other four.
S. Choleraesuis var. Decatur, on the other hand, has a greater metabolic capacity but is also
far more genetically diverse [8]. Current biotyping schemes often lead to errors in identification [8],
and so molecular tests have been developed using multi locus sequence typing (MLST) [6].
However, the mapping of these sequence types to phylogenetically related clusters is not clean
and the association with animal hosts even less so [8]. The utility of these biotypes is therefore disputed.
The host restricted biotypes within the 6,7:c:1,5 group, (S. Paratyphi C to humans and S. Typhisuis
to pigs) are clearly distinguishable from S. Choleraesuis; this has led to the hypothesis that the adaptation
of salmonellae to humans by S. Typhi, Paratyphi A, B and C, is the result of convergent evolution of a
diverse set of Salmonella adapting to survive and transmit between human hosts [7]. Comparative
genomic studies on S. Typhi and Paratyphi A support this theory [9,10], but for S. Paratyphi B and C
the evolutionary trajectory is less clear. Sequencing of ancient DNA from humans suggests that the
6,7:c:1,5 group of Salmonella were far more common in the past than now and were part of a historic
clade (Ancient Eurasian Super Branch) which falls within the much larger extant S. enterica diversity.
The early members of this clade cluster with their pig-adapted modern counterparts [11].
Clinically, the disease caused by S. Typhi and Paratyphi A is indistinguishable [12], but the
evidence from a search of the accessible published literature that S. Paratyphi C causes only enteric
fever is less clear. Rather, the clinical descriptions range from opportunistic infection resembling
sepsis [13–16] to classic enteric fever [17]. This presentation, in some cases, is very similar to the
infection caused in humans by the pig-adapted S. Choleraesuis [18]. The clinical picture is confused by
difficulties in identifying S. Paratyphi C in the laboratory, but it is possible that this human restricted
pathogen has undergone very different selective pressures to S. Typhi and Paratyphi A. If S. Paratyphi
C has evolved convergently with S. Typhi and Paratyphi A, then the genome sequence should reveal
this through the accumulation, across serotypes, of genetic changes that cause lesions in the pathways
associated with host adaptation [19]. Here, we investigate this by describing the genomic lesions
present in the genomes of 58 isolates from the 6,7:c:1,5 group, and comparing the evolutionary dynamics
of this important group with those reported for S. Typhi and Paratyphi A.
Microorganisms 2020, 8, 657 3 of 10
2. Materials and Methods
2.1. Isolates
All 6,7:c1,5 strains used in the study are listed in Table 1, along with accession numbers for the raw
sequence data. We assembled a collection of 6,7:c1,5 isolates for genome sequencing and supplemented
these with publicly available sequences where necessary.
2.2. DNA Preparation
All isolates were cultured on non-selective agar (LB agar, Difco, Oxford, United Kingdom) for
purity checking, and in non-selective broth (LB broth, Difco) for DNA extraction. DNA was extracted
using a genomic DNA extraction (Sigma, Gillingham, United Kingdom) and sequenced using the
Illumina Genome Analyzer II (Cambridge, United Kingdom), as previously described [20].
2.3. Genomes from Databases
A search was performed in Enterobase [21] for entries with the antigenic formula 6,7:c:1,5.
An additional 2 genome sequences were identified and included in this study, S. Choleraesuis var.
Decatur SARB70 (ERR3482081) and S. Paratyphi C RKS4594 (CP000857). 21 S. Typhi genomes, CT18
(accession AL513382), Ty2 (AE014613) and 19 from [22], and 2 S. Paratyphi A genomes, ATCC 9150
(CP000026) and AKU_12601 (FM200053) were also used.
2.4. Reference Genome Assembly
For the S. Typhisuis 61-6 and S. Paratyphi C 66-8 reference genomes, a high-quality sequence
was assembled using data from two sequencing platforms. DNA was sequenced on both 454 Roche
GS FLX Titanium (paired end library with 3kb insert; Connecticut, United States) and the Illumina
Genome Analyzer II (200–300bp standard paired end library run in one lane for 37 cycles). Illumina
sequences were assembled using Velvet [23] and combined with 454 sequences using Newbler (Roche).
The combined assemblies were converted to Gap4 databases [24], to guide gap closure based upon
454 read pair information. ABACAS [25] was used to order and orient the fragmented assemblies
against the complete genomes of S. Enteritidis P125109 (accession AM933172) and S. Choleraesuis
SC-B67 (AE017220), enabling many small repeat regions to be correctly assembled. Finally, iCORN [26]
was used to correct the assembled sequences using the Illumina data and checked in the Gap4 database.
Initial genome annotation was carried out using annotation transfer via RATT [27] from S. Choleraesuis
SC-B67. Genome assemblies are available under the project accession PRJEB37271.
2.5. Sequence QC
Where necessary, sequence data were trimmed using Trimmomatic (Galaxy v0.38.0) [28] with
sliding window trimming of 4;20, leading and trailing trimming at quality 3 and appropriate adapter
clipping (GAII or HiSeq).
2.6. Comparative Genomics
The identification of genomic lesions (mutations resulting in premature stop codons, frameshifts
or insertion/deletions relative to an intact version of the gene), and comparison between genomes,
was carried out using Artemis Comparison Tool (v10) [29]. For each identified lesion, the appropriate
reference genome annotation was amended to accurately reflect the mutation, and therefore allow
inclusion of these genomic features in downstream analysis. Velvet assemblies were generated for all
isolates sequenced in this study. Per cluster, all mutations leading to genomic lesions in the reference
genome were checked for their presence in at least 2 other draft genome assemblies from that cluster.
The comparators (S. Choleraesuis, RKS1235 and RKS1249; S. Paratyphi C, 6610 and 664; S. Typhisuis,
38K and 871997) were chosen for their divergent positions within the phylogeny. Genomic lesions
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were deemed core if the same mutation was present in both, or variable if the mutation was absent in
one or both sequences. OrthoMCL [30] with default parameters was used to determine orthologues
between the three 6,7:c:1,5 genomes, S. Typhi CT18 and S. Paratyphi A AKU_12601. S. Enteritidis
P125109 was also used as a comparator. All core disrupted genes were compared via orthology to
identify which were shared or unique to each cluster. Core genomic lesions were also identified for
S. Typhi across 19 genomes and S. Paratyphi A across the 2 publicly available genomes at the time.
2.7. Pathway Comparison
Lists of disrupted genes were overlaid onto the metabolic pathway overview of the S. Typhi CT18
pathway/genome database [31] to identify disrupted pathways and transport reactions. Disrupted
pathways were compared between the 5 Salmonella to produce an UpSet plot [32].
3. Results and Discussion
3.1. Reductive Evolution and Genome Degradation
We generated a core SNP phylogeny from the genomes of 58 isolates to investigate the relationship
between related 6,7:c:1,5 biotypes of S. enterica subspecies I (Figure 1). These included 17 isolates of
S. Paratyphi C which spanned a range of 57 years and were collected from Europe, Africa and the
Middle East (Table S1).
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The two S. Decatur genomes showed more SNP variation between them than was found across
all of the remaining biotypes (Figure S1), and so they were removed from the phylogeny. It is
generally accepted that organisms classified as S. Decatur represent a very diverse group which
should be considered separate from other 6,7:c:1,5 Salmonella. The remaining strains grouped into four
phyloclusters (Figure 1, supported by hierBAPS analysis, Table S1). We also prepared an extended
phylogeny, including an additional 116 assemblies from Enterobase, which confirmed the phylogenetic
relationships were robust (Figure S1). The separation of these clusters was matched to the currently
accepted classification scheme: 1, S. Typhisuis; 2, S. Paratyphi C; 3, S. Choleraesuis var. sensu stricto;
4, S. Choleraesuis var. Kunzendorf. This phylogeny confirmed that the isolates included in this study
were typical of the 6,7:c:1,5 group, and also allowed us to select representative genomes for comparative
analyses. For this analysis, the two biotypes of S. Choleraesuis were considered together because the
core variation across the two groups was similar to that seen across the S. Typhisuis group, and this
study focused on the human adaptation of S. Paratyphi C, S. Choleraesuis var. sensu stricto and var.
Kunzendorf are both associated with pigs.
In bacteria restricted to a niche, such as infection of the human host, the accumulation of mutations
that disrupt gene sequences (termed “pseudogenes”) is well described [10]. The term pseudogene
typically infers a loss of gene function but that is not always accurate, as many of these changes
(deletions, insertions or major amino acid substitutions) can cause a change of function [33,34], and so
here we use the term genomic lesion (GL) to infer changes that are predicted to have an impact on
phenotype but do not necessarily cause loss of function. The association of genomic lesions with host
adaptation is an active research area [35]; however, grouping genomic lesions by functional impact
remains challenging. We have therefore treated all GLs (mutations resulting in premature stop codons,
frameshifts or insertion/deletions relative to an intact version of the gene) as equal. We found that the
number of GLs per serotype was much greater for S. Paratyphi A and S. Typhi than for S. Paratyphi C,
suggesting a potentially shorter evolutionary time period for accumulation. However, the presence
of S. Paratyphi C DNA found in ancient human samples [36,37], coupled with the descriptions of
S. Paratyphi C as being very common in more ancient periods of human history suggests that the
effective population size was at least as large as S. Typhi. This, in turn, suggests a different selective
pressure driving the preservation of metabolic diversity, by the removal of genomic lesions from
the population. For S. Paratyphi C then, a history of colonisation and transmission between varied
environments seems more likely than one of being restricted to the human host. However, it is possible
that S. Paratyphi C is at an early point along the pathway to human restriction, and so we looked for
signs of early adaptation to the human host.
We performed comparative genomics within and between multiple genome sequences of
S. Paratyphi C, S. Typhisuis and S. Choleraesuis, to determine if genome degradation was evident. At the
time of sequencing, a high-quality contiguous reference genome only existed for S. Choleraesuis SCB67;
we therefore generated references for both S. Paratyphi C and S. Typhisuis (Table S1). Within each
biotype, a core set of genomic lesions was identified by comparison of the reference with two other
members of that group, selected to represent the diversity within the group (Table S2). Any lesion that
was absent from one or more of the sequences was considered variable and not included. All the 6,7:c:1,5
biotypes sequenced here, showed similar levels of genome degradation, with just over 100 genomic
lesions seen in each genome representative (Figure 2). When compared with the core genomic lesions of
the human restricted serotypes, it was evident that the scale of genome degradation was much greater
in the two classic human restricted serotypes S. Typhi (186 lesions) and Paratyphi A (144 lesions).
To understand the impact of these differences in genome degradation, we investigated the possible
functional consequences of these genomic lesions.
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Figure 2. Distribution of disrupted genes. Network of shared and unique disrupted genes in S. Paratyphi
C (SPC), S. Typhisuis (STS), S. Choleraesuis (SCH), S. Paratyphi A (SPA) and S. Typhi (STY). Yellow
circles are false nodes representing each Salmonella. Diamonds indicate a single genomic lesion; size
and colour indicate how many Salmonella share that lesion. Black lines connect Salmonella to genomic
lesions. Lesions unique to each Salmonella are shown as fans around the false nodes. Mbp, megabase
pairs; GL, genomic lesion. Dashed circles indicate lesions shared between SPC and STY and/or SPC
and SPA. 1: torC, ratC, STY4541, STY2432, STY1834, STY1781; 2: slrP and fliB; 3: STY4472, STY4044,
ST 1408, STY1353.
3.2. Genomic Lesions are Functionally Distinct
Genomic lesions were located in metabolic pathways according to a pathway/genome database
generated for S. Typhi (Table S3). This enabled us to determine which (potentially different)
lesions affected the same pathways or transporters between the three 6,7:c1,5 representatives and
S. Typhi/Paratyphi A (Figure 3). The intersection of affected pathways and transporters revealed
that S. Paratyphi C had no le ions in pathways/transporters that were also degraded in S. Typhi or
i ( igure S2). However, th re w re two genomic lesions that were comm n to all three
, sentatives and S. Typhi/Paratyphi A: sopA and mglA. The former encodes a Type Three
secretion system (T3SS) effector protein secreted by the T3SS encoded on Salmonella Pathogenicity
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Island 1 (SPI-1), and the latter encodes a galactoside transporter. SPI-1 effectors are associated with the
invasion of host intestinal cells and subsequent enteritis [38], and so the disruption of SopA through
genomic lesion in all of the Salmonella investigated here is not surprising. Disruption of mglA has
previously been reported in other host-adapted Salmonella [39], which combined with our findings
suggests that the gene is linked to the former generalist lifestyle of all of these adapted salmonellae.
Microorganisms 2019, 7, x 7 of 11 
 
secretion system (T3SS) effector protein secreted by the T3SS encoded on Salmonella Pathogenicity 
Island 1 (SPI-1), and th  latter encodes a galactoside transporter. I-1 effectors are associated with 
the invasio  of host intestinal cells and subsequent enteritis [38], and so the disruption of SopA 
through genomic lesion in all of the Salmonella investigated here is not surprising. Disruption of mglA 
has previously been reported in other host-adapted Salmonella [39], which combined with our 




Figure 3. Distribution of disrupted pathways. Annotated UpSet plot of shared and unique disrupted 
pathways. Number of genes disrupted in pathways given above the columns (includes multiple genes 
disrupted in same pathway). Open circles: no disrupted pathways are shared between S. Typhi, S. 
Paratyphi A and S. Paratyphi C. 
For the 6,7:c:1,5 biotypes we saw 29 genomic lesions, two of which impacted two shared 
pathways/transporters: arabinose degradation and a PTS fructose transport system, which have not 
been linked to bacterial colonisation of pigs previously. This most likely reflects their shared ancestry 
but may be the result of selection for colonisation of a shared habitat. We therefore examined the 
exact nature of the mutations causing these genomic lesions: the same base pair change at the same 
site was considered to be inheritance whereas a different mutation in the same gene (or pathway) 
was considered to show selection indicative of convergent evolution. The lesions affecting arabinose 
degradation and PTS fructose transport were identical and thus considered inheritance. This leaves 
open the possibility that the ancestor of S. Paratyphi C evolved as a pig pathogen, which then crossed 
the species barrier into humans. If this was the case, it seems likely that S. Paratyphi C has crossed 
from pigs to become an opportunistic human pathogen that has subsequently become restricted to 
the human host. S. Paratyphi C and S. Choleraesuis cause a similar pathology in humans but S. 
Paratyphi C has lost the ability to infect pigs. This hypothesis is supported by the reporting of 
Salmonella genomes in ancient DNA studies [11]. The genomes of Salmonella from 400 to 900 years ago 
cluster with modern S. Paratyphi C, but the older genomes (1600–5000 years old) cluster more closely 
with the pig-adapted S. Choleraesuis. This supports the hypothesis that the ancestor of S. Paratyphi 
C was adapted to pigs and that host restriction in humans actually represents an evolutionary dead 
end, explaining why S. Paratyphi C is so rare today. 
Five pathways/transporters were found to be disrupted in both S. Typhi and Paratyphi A, of 
which two were shared by them alone. For S. Typhi/Paratyphi A, approximately 25% of their genome 
Figure 3. Distribution of disrupted pathways. tated UpSet pl t of share a d un q e disrupted
pathways. Number of genes disrupted in pathways given above the columns (includes multiple genes
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S. Paratyphi A and S. Paratyphi C.
For the 6,7:c:1,5 biotypes we saw 29 genomic lesions, two of which impacted two shared
pathways/transporters: arabinose degradation and a P S fructose transport system, which have not
been linked to bacterial coloni ation o pigs prev usly. T is most likely reflects their shared ancestry
but may be the result of selection for colonisation of a shared habitat. We therefore exa ined the
exact nature of the mutations causing these genomic lesions: the same base pair change at the same
site was considered to be inheritance whereas a different mutation in the same gene (or pathway)
was considered to show selection indicative of convergent evolution. The lesions affecting arabinose
degradation and PTS f uctose tr nsport were identical and thus considered inheritance. This leaves
open the poss bility that the ancestor of S. Par typhi C evolved a a pig pathogen, which hen crossed
the species barrier into humans. If this was the case, it seems likely that S. Paratyphi C has crossed
from pigs to become an opportunistic human pathogen that has subsequently become restricted to the
human host. S. Paratyphi C and S. Choleraesuis cause a similar pathology in humans but S. Paratyphi
C has lost the ability to infect pigs. This hypothesis is supported by the reporting of Salmonella genomes
in ancient DNA stu ies [11]. The gen m of Salmonella from 400 to 900 years ago cluste with modern
S. Paratyphi C, but the older genomes (1600–5000 years old) cluster more closely with the pig-adapted
S. Choleraesuis. This supports the hypothesis that the ancestor of S. Paratyphi C was adapted to pigs
and that host restriction in humans actually represents an evolutionary dead end, explaining why
S. Paratyphi C is so rare today.
Five pathways/transporters were found to be disrupted in both S. Typhi and Paratyphi A, of which
two were shared by them alone. For S. Typhi/Paratyphi A, approximately 25% of their genome is
shared through a recombination event, and the mutations causing GLs in this region of the genome
accordingly have identical base pair changes [9]. However, outside of this shared region there are many
mutations casing GLs that are clearly the result of convergent evolution: independent mutations linked
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to the disruption of the same metabolic pathways. Our analysis agrees with this finding, we identified
genomic lesions in 11 genes and two pathways present only in S. Typhi and Paratyphi A, once all
shared lesions with the 6,7:c:1,5 biotypes had been considered. Of these lesions, some were identical
mutations and some were independent [9], suggesting convergent evolution by both selection for
independent mutations and horizontally acquired characteristics.
3.3. Anaerobic Respiration Intact in S. Paratyphi C
The link between host adaptation (leading towards restriction) in Salmonella is perhaps best
described for the metabolic functions associated with tetrathionate. Tetrathionate reduction allows the
bacterial cell to carry out anaerobic respiration, this in turn increases the growth rate in the anaerobic
environment of the animal gut and generates specific metabolic end products which stimulate
inflammatory diarrhoea and in turn transmission between hosts [40]. The loss of anaerobic metabolism
through the disruption of tetrathionate reduction is a hallmark of host adaptation, where a balance
between pathogenicity and long-term colonisation of the host is the evolutionary strategy, rather than
population expansion through rapid transmission. In Salmonella, disruption of anaerobic respiration
is seen in S. Typhi, S. Paratyphi A and the S. Gallinarum/Pullorum group (restricted to birds) [10,19].
For S. Paratyphi C no such disruption was seen, the anaerobic respiration pathways were intact. In fact,
only two genomic lesions were shared solely between S. Paratyphi C, S. Typhi and S. Paratyphi A (slrP
and fliB), and these did not map to metabolic functions.
4. Conclusions
For S. Typhi and Paratyphi A, there is a clear genomic signal that suggests convergent evolution
during adaptation and eventual restriction to the human host. In this study of 17 S. Paratyphi C
genomes, we found: (i) the level of genome degradation caused by mutational disruption was much
lower than in other host-restricted Salmonella, (ii) the metabolic pathways involved did not match
the pathways disrupted in the human restricted Salmonella, and (iii) the acquisition of mutations
appeared to be through inheritance from the ancestor with S. Choleraesuis, rather than by the selection
of randomly occurring errors of DNA replication. In short, this suggests that convergent evolution
does not explain the host restriction of S. Paratyphi C. Indeed, since anaerobic respiration is intact in
S. Paratyphi C, we hypothesise that pathogenicity would be more similar to non-typhoidal Salmonella
than to the enteric fever group. This has implications for both biological understanding and risk
assessment for safety in clinical laboratories.
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circles are false nodes representing each Salmonella. Diamonds indicate a single disrupted pathway (connected by
straight lines) or transporters (connected by wavy lines); size and colour indicate how many Salmonella share
that disrupted pathway/transporter. Disrupted pathways/transporters unique to each Salmonella are shown as
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